Tilray | TRLY - Assets

Stock Price
10.85
Daily Change
0.49 4.73%
Monthly
-9.88%
Yearly
835.34%
Q1 Forecast
10.37

Tilray reported $2.07B in Assets for its fiscal quarter ending in March of 2025.





Assets Change Date
Acasti Pharma USD 66.58M 3.22M Sep/2025
Akebia Therapeutics USD 364.15M 18.56M Sep/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Aurora Cannabis CAD 756.86M 80.98M Sep/2025
Avita Medical AUD 58.13M 21.58M Jun/2025
Canopy Growth CAD 1.07B 165.17M Sep/2025
Cronos Group USD 1.18B 3.18M Sep/2025
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Moderna USD 12.34B 203M Dec/2025
Organigram Holdings CAD 562.21M 2.4M Sep/2025
Organon & Co USD 13.55B 52M Sep/2025
Revvity USD 12.17B 29.46M Dec/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Tilray USD 2.07B 1.33B Mar/2025
Viatris USD 37.92B 491.1M Sep/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025